ResMed PE Ratio 2010-2025 | RMD
Current and historical p/e ratio for ResMed (RMD) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ResMed PE ratio as of June 24, 2025 is 28.18.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ResMed PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-25 | 257.91 | 28.95 | |
| 2025-03-31 | 223.37 | $8.91 | 25.07 |
| 2024-12-31 | 227.68 | $8.47 | 26.88 |
| 2024-09-30 | 242.52 | $7.55 | 32.12 |
| 2024-06-30 | 189.71 | $6.93 | 27.38 |
| 2024-03-31 | 195.83 | $6.51 | 30.08 |
| 2023-12-31 | 169.68 | $6.05 | 28.05 |
| 2023-09-30 | 145.39 | $6.16 | 23.60 |
| 2023-06-30 | 214.28 | $6.10 | 35.13 |
| 2023-03-31 | 214.35 | $5.87 | 36.52 |
| 2022-12-31 | 203.32 | $5.51 | 36.90 |
| 2022-09-30 | 212.81 | $5.35 | 39.78 |
| 2022-06-30 | 203.98 | $5.31 | 38.41 |
| 2022-03-31 | 235.47 | $5.31 | 44.34 |
| 2021-12-31 | 252.47 | $3.55 | 71.12 |
| 2021-09-30 | 255.04 | $3.41 | 74.79 |
| 2021-06-30 | 238.21 | $3.24 | 73.52 |
| 2021-03-31 | 187.10 | $3.13 | 59.78 |
| 2020-12-31 | 204.58 | $4.79 | 42.71 |
| 2020-09-30 | 164.70 | $4.66 | 35.34 |
| 2020-06-30 | 184.07 | $4.27 | 43.11 |
| 2020-03-31 | 140.88 | $3.53 | 39.91 |
| 2019-12-31 | 147.89 | $3.14 | 47.10 |
| 2019-09-30 | 128.59 | $2.90 | 44.34 |
| 2019-06-30 | 115.81 | $2.80 | 41.36 |
| 2019-03-31 | 98.34 | $3.08 | 31.93 |
| 2018-12-31 | 107.29 | $3.11 | 34.50 |
| 2018-09-30 | 108.29 | $2.32 | 46.68 |
| 2018-06-30 | 96.92 | $2.19 | 44.25 |
| 2018-03-31 | 91.81 | $2.14 | 42.90 |
| 2017-12-31 | 78.67 | $2.00 | 39.33 |
| 2017-09-30 | 71.18 | $2.47 | 28.82 |
| 2017-06-30 | 71.68 | $2.41 | 29.74 |
| 2017-03-31 | 65.93 | $2.29 | 28.79 |
| 2016-12-31 | 56.57 | $2.30 | 24.60 |
| 2016-09-30 | 58.73 | $2.40 | 24.47 |
| 2016-06-30 | 57.05 | $2.43 | 23.48 |
| 2016-03-31 | 51.90 | $2.45 | 21.18 |
| 2015-12-31 | 47.94 | $2.46 | 19.49 |
| 2015-09-30 | 45.27 | $2.46 | 18.40 |
| 2015-06-30 | 49.80 | $2.47 | 20.16 |
| 2015-03-31 | 63.10 | $2.47 | 25.55 |
| 2014-12-31 | 49.06 | $2.46 | 19.94 |
| 2014-09-30 | 42.89 | $2.42 | 17.72 |
| 2014-06-30 | 43.83 | $2.40 | 18.26 |
| 2014-03-31 | 38.50 | $2.29 | 16.81 |
| 2013-12-31 | 40.34 | $2.24 | 18.01 |
| 2013-09-30 | 45.03 | $2.17 | 20.75 |
| 2013-06-30 | 38.28 | $2.10 | 18.23 |
| 2013-03-31 | 39.19 | $2.13 | 18.40 |
| 2012-12-31 | 35.00 | $1.99 | 17.59 |
| 2012-09-30 | 33.93 | $1.88 | 18.05 |
| 2012-06-30 | 26.04 | $1.72 | 15.14 |
| 2012-03-31 | 25.80 | $1.56 | 16.54 |
| 2011-12-31 | 21.20 | $1.46 | 14.52 |
| 2011-09-30 | 24.03 | $1.41 | 17.04 |
| 2011-06-30 | 25.83 | $1.44 | 17.94 |
| 2011-03-31 | 25.04 | $1.41 | 17.76 |
| 2010-12-31 | 28.92 | $1.39 | 20.88 |
| 2010-09-30 | 27.39 | $1.32 | 20.83 |
| 2010-06-30 | 25.38 | $1.23 | 20.63 |
| 2010-03-31 | 26.57 | $1.19 | 22.42 |
| 2009-12-31 | 21.82 | $1.13 | 19.39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.523B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $147.507B | 30.84 |
| EssilorLuxottica (ESLOY) | France | $130.320B | 0.00 |
| Medtronic (MDT) | Ireland | $110.401B | 15.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| Agilent Technologies (A) | United States | $33.417B | 21.78 |
| GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
| Terumo (TRUMY) | Japan | $27.294B | 35.45 |
| Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
| Insulet (PODD) | United States | $21.880B | 85.88 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
| Baxter (BAX) | United States | $15.698B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.474B | 22.53 |
| Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
| Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
| Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
| Haemonetics (HAE) | United States | $3.510B | 15.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.221B | 23.75 |
| Envista Holdings (NVST) | United States | $3.210B | 26.68 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
| LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
| AtriCure (ATRC) | United States | $1.621B | 0.00 |
| Acuren (TIC) | United States | $1.311B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
| Neogen (NEOG) | United States | $1.070B | 13.69 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
| Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
| InMode (INMD) | Israel | $0.870B | 8.76 |
| CeriBell (CBLL) | United States | $0.710B | 0.00 |
| Evolus (EOLS) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.578B | 4.79 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
| Valneva SE (VALN) | France | $0.477B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.22 |
| Brainsway (BWAY) | Israel | $0.232B | 61.30 |
| Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.229B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| MacroGenics (MGNX) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 59.43 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |